GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus

被引：0
|
作者：
Claire Greenhill
机构：
[1] Nature Reviews Endocrinology,
来源：
Nature Reviews Endocrinology | 2022年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：331 / 331
相关论文
共 50 条
  • [41] GLP1 AND INSULIN GLARGINE TREATMENT PATTERNS AMONG TYPE 2 DIABETES PATIENTS IN MAJOR EU MARKETS
    Divino, V
    Hallinan, S.
    Dekoven, M.
    Varol, N.
    Lee, W. C.
    Reaney, M. D.
    VALUE IN HEALTH, 2013, 16 (07) : A453 - A453
  • [42] The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain
    Bae, Choon Sang
    Song, Juhyun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):
  • [43] Design, synthesis, and application of GLP1 agonist-ASO conjugates to gene silencing in pancreatic beta cells
    Knerr, Laurent
    Hayen, Ahlke
    Olwegard-Halvarsson, Maria
    Seth, Punit
    Prakash, Thazha
    Drury, William
    Ammala, Carina
    Ahlstdedt, Ingela
    Stillemark-Billton, Pia
    Wennberg-Huldt, Charlotte
    Andersson, Eva-Marie
    Valeur, Eric
    Jansson-Lofmark, Rasmus
    Janzen, David
    Sundstrom, Linda
    Meuller, Johan
    Claesson, Josefine
    Andersson, Patrik
    Johansson, Camilla
    Lee, Richard
    Monia, Brett
    Andersson, Shalini
    Bjorkbom, Anders
    Cavallin, Erika
    Li, Xueqing
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [44] Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice
    Fujikawa, Teppei
    Chuang, Jen-Chieh
    Sakata, Ichiro
    Ramadori, Giorgio
    Coppari, Roberto
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (40) : 17391 - 17396
  • [45] A MUTATION IN MITOCHONDRIAL TRANSFER RNA(LEU(UUR)) GENE IN A PEDIGREE WITH MATERNALLY TRANSMITTED INSULIN-DEFICIENT TYPE OF DIABETES-MELLITUS
    KADOWAKI, T
    KADOWAKI, H
    TOBE, K
    MORI, Y
    SAKURA, H
    HAYAKAWA, T
    HAGURA, R
    YAZAKI, Y
    AKANUMA, Y
    DIABETES, 1993, 42 : A95 - A95
  • [46] Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus
    Christensen, Mikkel
    Knop, Filip K.
    Holst, Jens J.
    Vilsboll, Tina
    IDRUGS, 2009, 12 (08) : 503 - 513
  • [47] Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus
    Briones, Mariele
    Bajaj, Mandeep
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (08) : 1055 - 1064
  • [48] Real-world evaluation of insulin requirements after GLP1 agonist or SGLT2 inhibitor initiation and titration
    George, Jamie
    Lobkovich, Alison
    Nardolillo, Joseph
    Farhat, Nada
    Kolander, Sarah
    Thomas, Emily
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (14) : 1151 - 1157
  • [49] Successful Use of Hybrid Closed Loop Insulin Pumps with GLP1 Agonists in Diabulimia and Disordered Eating in Type 1 Diabetes
    Basavaraju, Navya
    Jones, Annamarie
    Moulik, Probal
    DIABETES, 2024, 73
  • [50] DELAYED REMOVAL OF I-125 LABELED VERY LOW-DENSITY-LIPOPROTEIN FROM PLASMA OF RATS WITH INSULIN-DEFICIENT DIABETES-MELLITUS
    GOLAY, A
    HOLLENBECK, CB
    CHEN, YDI
    HORMONE AND METABOLIC RESEARCH, 1992, 24 (09) : 405 - 408
12345